0000904454-15-000051.txt : 20150205 0000904454-15-000051.hdr.sgml : 20150205 20150205144620 ACCESSION NUMBER: 0000904454-15-000051 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150205 DATE AS OF CHANGE: 20150205 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Neothetics, Inc. CENTRAL INDEX KEY: 0001618835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208527075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88576 FILM NUMBER: 15579745 BUSINESS ADDRESS: STREET 1: 9191 TOWNE CENTRE DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: (858) 750-1008 MAIL ADDRESS: STREET 1: 9191 TOWNE CENTRE DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92122 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DOMAIN PARTERS VII L P CENTRAL INDEX KEY: 0001374150 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE PALMER SQUARE SUITE 515 CITY: PRINCETON STATE: NJ ZIP: 08542 BUSINESS PHONE: 609-683-5656 MAIL ADDRESS: STREET 1: ONE PALMER SQUARE SUITE 515 CITY: PRINCETON STATE: NJ ZIP: 08542 SC 13G 1 s13g_021415-neothetics.htm SCHEDULE 13G FOR NEOTHETICS, INC. BY DOMAIN PARTNERS VII, L.P. s13g_021415-neothetics.htm
 
 



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
_____________________

SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No.  )1

Neothetics, Inc.
(Name of Issuer)
 
Common Stock, $0.0001 par value
(Title of Class of Securities)
 
64066G101
(CUSIP Number)
 
December 31, 2014
Date of Event Which Requires Filing of this Statement


Check the appropriate box to designate the rule pursuant to which this Schedule is Filed:

[   ] Rule 13d-1(b)
[   ] Rule 13d-1(c)
[X] Rule 13d-1(d)



_______________________

1The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.  The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
 
 

 

 
 
 
 
 
CUSIP No. 64066G101

1.
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) (VOLUNTARY)
 
Domain Partners VII, L.P.
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)            [X]
(b)           [   ]
3.
SEC USE ONLY
 
  
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING
PERSON WITH:
5.
SOLE VOTING POWER
3,091,643 shares of Common Stock *
6.
SHARED VOTING POWER
-0-
7.
SOLE DISPOSITIVE POWER
3,091,643 shares of Common Stock *
8.
SHARED DISPOSITIVE POWER
-0-
9.
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,091,643 shares of Common Stock *
10.
 
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
11.
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
22.3% **
12.
TYPE OF REPORTING PERSON
PN

* As of December 31, 2014
** Based on 13,868,032 shares of Common Stock outstanding as of December 31, 2014

 
 

 
 
2
 
 
 
CUSIP No. 64066G101

1.
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) (VOLUNTARY)
 
DP VII Associates, L.P.
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)            [X]
(b)           [   ]
3.
SEC USE ONLY
  
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING
PERSON WITH:
5.
SOLE VOTING POWER
48,025 shares of Common Stock *
6.
SHARED VOTING POWER
-0-
7.
SOLE DISPOSITIVE POWER
48,025 shares of Common Stock *
8.
SHARED DISPOSITIVE POWER
-0-
9.
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
48,025 shares of Common Stock *
10.
 
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
11.
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
0.3% **
12.
TYPE OF REPORTING PERSON
 
PN

* As of December 31, 2014
** Based on 13,868,032 shares of Common Stock outstanding as of December 31, 2014
 
 
 

 
 
3
 
 
 
CUSIP No. 64066G101

 
Schedule 13G

Item 1(a)
Name of Issuer:
   
 
Neothetics, Inc.
   
Item 1(b)
Address of Issuer’s Principal Executive Offices:
   
 
9191 Towne Centre Drive, Suite 400
 
San Diego, CA  92122
   
Item 2(a)
Name of Person Filing:
   
 
This statement is being filed by Domain Partners VII, L.P., a Delaware limited partnership (“Domain VII”), and DP VII Associates, L.P., a Delaware limited partnership (“DP VII A”) (together, the “Reporting Persons”).
   
Item 2(b)
Address of Principal Business Office:
   
 
One Palmer Square
 
Princeton, NJ  08542
   
Item 2(c)
Place of Organization:
   
 
Domain VII:  Delaware
 
DP VII A:  Delaware
   
Item 2(d)
Title of Class of Securities:
   
 
Common Stock, $0.0001 par value
   
Item 2(e)
CUSIP Number:
   
 
64066G101
   
Item 3
Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b):
   
 
Not applicable.
   
Item 4
Ownership.
   
(a) through (c):
The information set forth in Items 5 through 9 and 11 of the cover pages to this Schedule 13G is incorporated herein by reference. In addition, as of December 31, 2014 Domain Associates, L.L.C., an affiliate and the investment manager of the Reporting Persons, directly beneficially owned 3,934 shares of Common Stock, or less than 0.1% of the Common Stock outstanding.

 
 

 
 
4
 
 
 
CUSIP No. 64066G101

Item 5
Ownership of Five Percent or Less of a Class:
   
 
Not applicable.
   
Item 6
Ownership of More than Five Percent on Behalf of Another Person:
   
 
Not applicable.
   
Item 7
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Company:
   
 
Not applicable.
   
Item 8
Identification and Classification of Members of the Group:
   
 
See Exhibit 2.
   
Item 9
Notice of Dissolution of Group:
   
 
Not applicable.
   
Item 10
Certification:
   
 
Not applicable.
 
 

 

 
5
 
 
 
CUSIP No. 64066G101

 
SIGNATURE

After reasonable inquiry and to the best of their knowledge and belief, the undersigned hereby certify that the information set forth in this statement is true, complete and correct.

Dated:  February 3, 2015

 
DOMAIN PARTNERS VII, L.P.
 
 
By:
One Palmer Square Associates VII, L.L.C., General Partner
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member
 
 
 
DP VII ASSOCIATES, L.P.
 
 
By:
One Palmer Square Associates VII, L.L.C., General Partner
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member
 

 

 


 
6
 
 
 
CUSIP No. 64066G101

 
EXHIBIT 1

 
JOINT FILING AGREEMENT
 
 
The undersigned hereby agree that the statement on Schedule 13G to which this Agreement is annexed as Exhibit 1, and any amendments thereto, is and will be filed on behalf of each of them in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
 
Dated:  February 3, 2015
 

 
DOMAIN PARTNERS VII, L.P.
 
 
By:
One Palmer Square Associates VII, L.L.C., General Partner
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member
 
 
 
DP VII ASSOCIATES, L.P.
 
 
By:
One Palmer Square Associates VII, L.L.C., General Partner
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member
 

 

 


 
7
 
 
 
CUSIP No. 64066G101

 
EXHIBIT 2

Identification and Classification of Members of the Group

Domain Partners VII, L.P. and DP VII Associates, L.P. are filing this statement on Schedule 13G as a group.

Domain Partners VII, L.P. is a Delaware limited partnership.  Its sole general partner is One Palmer Square Associates VII, L.L.C., a Delaware limited liability company.

DP VII Associates, L.P. is a Delaware limited partnership.  Its sole general partner is One Palmer Square Associates VII, L.L.C., a Delaware limited liability company.
 
 
 
 
 
 
8